gemcitabine (Bedford Laboratories)
Welcome to the PulseAid listing for the gemcitabine drug offered from Bedford Laboratories. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Bedford Laboratories |
NON-PROPRIETARY NAME: | gemcitabine |
SUBSTANCE NAME: | GEMCITABINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-03-19 |
END MARKETING DATE: | 0000-00-00 |
gemcitabine HUMAN PRESCRIPTION DRUG Details:
Item Description | gemcitabine from Bedford Laboratories |
LABELER NAME: | Bedford Laboratories |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40(mg/mL) |
START MARKETING DATE: | 2012-03-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55390-391_4cef5f77-82b5-ba03-1f26-4fdeb8af63fd |
PRODUCT NDC: | 55390-391 |
APPLICATION NUMBER: | ANDA091365 |
Other GEMCITABINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: